Active · per the CBE, 15 September 2026

VEROVIR PHARMA

BE0452353263

Rechtspersoon Public limited company 1 establishment

VEROVIR PHARMA is a bank in Charleroi. Public Limited, started on 31 March 1994, 1 establishment.

Rue du Gallois 2G, 6032 Charleroi

Behind the company: HENRI LEDOUX.

Active for

32 year, 5 months

Financials

Financial year 2025

VEROVIR PHARMA from Charleroi, company number BE0452353263, closed financial year 2025 with a result of € 49,471 after tax. For that financial year VEROVIR PHARMA recorded a gross margin of € 154,027 and equity of € 1 million. Compared with financial year 2024, the result moved from € 22,556 to € 49,471. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.

What it is worth Growing

€ 1 million

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 49,471

▲ 119% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 420,278

▲ € 325,403 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 806,732.

Debts at end 2025

Bank debt

€ 700

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 3,340

▲ 33% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,566

▼ 19% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 108,481 € 70,355 € 91,061 € 154,027 ▲ 69%
Profit after taxes € 39,415 € 5,582 € 22,556 € 49,471 ▲ 119%
Equity € 927,524 € 933,105 € 955,661 € 1,005,132 ▲ 5%
Total debts € 6,292 € 11,344 € 14,087 € 11,739 ▼ 17%
Cash € 198,328 € 247,906 € 94,875 € 420,278 ▲ € 325,403
Land & buildings € 530,818 € 504,641 € 480,834 € 454,471 ▼ 5%
Retained profit € 729,124 € 734,705 € 757,261 € 806,732 ▲ 7%
Bank debt € 0 € 0 € 0 € 700
Balance sheet total € 933,815 € 944,449 € 969,748 € 1,016,871 ▲ 5%

Key figures of VEROVIR PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VEROVIR PHARMA?

What happened at VEROVIR PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 49,471 (▲ 119% vs 2024). Source: NBB ↗
  • New establishment in Charleroi. KBO
  • Start of the company according to the CBE. KBO
  • HENRI LEDOUX became a director. NBB

In short

From € 39,415 profit in 2022 to € 49,471 profit in 2025.

Paid € 40,225 in corporate taxes since 2022.

Best year ever: 2025, with € 49,471 profit.

Original PDFs at the National Bank ↗

A new publication or filing at VEROVIR PHARMA? We notify you, reason included.

Follow VEROVIR PHARMA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

  1. Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
  2. We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
  3. In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Yes, I want that
See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies
  • De Lijn 8 June 2026 New annual account 2025

    filed on 8 June 2026

    What was left

    € 20 k ▼ 91%

    Money in the bank

    € 178 k ▼ 98%

    Open the dossier →

  • NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
  • bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Real filings at the National Bank

Management

HENRI LEDOUX
VEROVIR PHARMA

Behind VEROVIR PHARMA is HENRI LEDOUX.

See the full network in the app

Directors

According to the 2025 annual accounts

HENRI LEDOUX

Director

since 1994

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Gallois 2G

6032 Charleroi

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0452.353.263
VAT number
BE 0452.353.263
Registered office
Rue du Gallois 2G, 6032 Charleroi
Names & denominations
VEROVIR PHARMA
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
31 March 1994
Peppol
Active · Active since 22 Dec 2025
Activities · NACE

Overige activiteiten van geldscheppende financiële instellingen

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What does VEROVIR PHARMA do?
VEROVIR PHARMA is a bank in Charleroi. Public Limited, started on 31 March 1994, 1 establishment.
What is the address of VEROVIR PHARMA?
The registered office of VEROVIR PHARMA is located at Rue du Gallois 2G, 6032 Charleroi.
Is VEROVIR PHARMA still active?
Yes. According to the CBE (15 September 2026) VEROVIR PHARMA is active, legal situation “Normale toestand”, started on 31 March 1994.
Is VEROVIR PHARMA registered on Peppol?
Yes, VEROVIR PHARMA is registered on the Peppol network with ID 0208:0452353263.
What is the enterprise number of VEROVIR PHARMA?
The enterprise number of VEROVIR PHARMA is BE0452353263.
When was VEROVIR PHARMA founded?
VEROVIR PHARMA was founded on 31 March 1994.